NEW YORK (Reuters) Oct 31 - Allergan Inc on Wednesday said U.S. regulators approved its combination glaucoma drug Combigan. The company said Combigan eye drops would combine "two strong agents in one bottle" -- brimonidine and timolol -- that work through different mechanisms to control intraocular pressure
FDA Approves Allergan Combo Eye Drop for Glaucoma
Technorati Tags: EMR
University of Maryland researchers suggest that carotenoids, particularly lycopene may protect the eye against oxidative damage and play a critical role in visual function. The identification of lycopene and a diverse range of dietary carotenoids in ocular tissues suggest that these carotenoids, as well as other nutrients found in tomato-based foods, may work in concert with lutein and zeaxanthin to provide protection against age related macular degeneration and other visual disorders.
ReplyDelete